CTOs on the Move

Overlook House

www.overlookhouse.org

 
Overlook House is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Dental Health Alliance

Dental Health Alliance is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthPort

HealthPort combines technology and strategic solutions to continually improve fragmented business processes for the healthcare community. The company offers revenue cycle management, electronic medical record, electronic document management, document

International Association for Medical Assisance to Travelers

International Association for Medical Assisance to Travelers is a Guelph, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Missouri Department of Health and Senior Services

We remain closely connected to the citizens we serve through responsive and timely communication, and we deeply value our role as a trusted source of information regarding health and senior issues.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.